Recent Finacing
Recent Raise
Nereid Therapeutics operates a drug-discovery platform using proprietary technologies to visualize and quantify liquid–liquid phase separation in mammalian cells via microscopy and computer vision, targeting cancers and neurodegenerative disorders.
